The potential association between GLP-1 RAs and suicidality has raised increasing concern following regulatory safety warnings
Microdosing may be considered when standard starting doses create barriers to tolerance or continuation
Call (877) 658-2244 MonFri, 8am5pm
Work on current weight loss
However, if you notice severe swelling, redness extending beyond 2 inches, fever, or trouble breathing, reach out to a healthcare provider right away
As a result, clinicians now have Read More Counseling Patients on Emerging GLP-1 Benefits: How to Balance Evidence and Expectations Apr 27, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 2,987 views Patients today are more informed than ever, but are they always getting the full picture